Published in Regul Pept on March 30, 2005
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer (2010) 1.01
Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT(2) receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung. J Mol Histol (2008) 0.86
Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction. Hypertension (2014) 0.83
AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation. Br J Pharmacol (2006) 0.83
Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension (2006) 2.89
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol (2007) 2.75
Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature (2002) 2.59
Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest (2004) 2.24
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08
Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation (2004) 2.04
Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol (2007) 1.87
Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol (2002) 1.80
Targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction. Circulation (2002) 1.76
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2006) 1.67
Issues for application of virtual microscopy to cytoscreening, perspectives based on questionnaire to Japanese cytotechnologists. Diagn Pathol (2008) 1.64
Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension (2006) 1.58
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res Treat (2005) 1.47
Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors. Proc Natl Acad Sci U S A (2006) 1.35
Distinct clinical, serological, and sonographic characteristics of hashimoto's thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab (2010) 1.34
Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin Cancer Res (2006) 1.31
Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler Thromb Vasc Biol (2005) 1.27
(Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res (2007) 1.21
A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J (2003) 1.21
Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol (2006) 1.21
Urokinase-type plasminogen activator system and breast cancer (Review). Oncol Rep (2005) 1.20
Clinicopathological significance of vascular endothelial growth factor-C in breast carcinoma with long-term follow-up. Mod Pathol (2003) 1.20
The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol (2004) 1.20
G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem (2005) 1.19
Clinicopathologic significance of intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation: a collaborative study with Member Institutes of The Japanese Society of Thyroid Surgery. Am J Clin Pathol (2007) 1.18
Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin Cancer Res (2003) 1.18
Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int (2006) 1.17
A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study. BMC Cancer (2010) 1.17
Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer Lett (2009) 1.16
Biological behavior and prognosis of familial papillary thyroid carcinoma. Surgery (2008) 1.15
p63 expression in normal, hyperplastic and malignant breast tissues. Breast Cancer (2002) 1.13
Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation (2002) 1.13
Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res (2009) 1.11
Distinct histopathological features of Hashimoto's thyroiditis with respect to IgG4-related disease. Mod Pathol (2012) 1.11
Immunohistochemistry of IgG4 can help subclassify Hashimoto's autoimmune thyroiditis. Pathol Int (2009) 1.10
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol (2007) 1.09
Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol (2002) 1.08
Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer (2010) 1.08
Targeting of the BRAF gene in papillary thyroid carcinoma (review). Oncol Rep (2009) 1.05
Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Clin Cancer Res (2003) 1.04
Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol Cell Biol (2003) 1.04
Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol (2008) 1.04
VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol (2005) 1.04
Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem (2008) 1.03
Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J Biol Chem (2002) 1.03
Cancer stem cell hypothesis in thyroid cancer. Pathol Int (2006) 1.03
Pyk2/CAKbeta tyrosine kinase activity-mediated angiogenesis of pulmonary vascular endothelial cells. J Biol Chem (2001) 1.02
A modified rapid Papanicolaou stain for imprint smears. Acta Cytol (2004) 1.02
Skull base metastasis from follicular thyroid carcinoma -two case reports-. Neurol Med Chir (Tokyo) (2010) 1.02
High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid (2005) 1.01
Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol (2009) 1.01
Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer (2012) 1.01
Angiotensin II type 2 receptor signaling significantly attenuates growth of murine pancreatic carcinoma grafts in syngeneic mice. BMC Cancer (2010) 1.01
Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res (2007) 1.00
Successful treatment for recurrent painful Hashimoto's thyroiditis by total thyroidectomy. Thyroid (2005) 1.00
Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2. Mol Endocrinol (2002) 0.99
Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circ Res (2004) 0.97
Parathyroid gland involvement by papillary carcinoma of the thyroid gland. Arch Pathol Lab Med (2002) 0.97
Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin Cancer Res (2002) 0.97
Predictive and prognostic markers for invasive breast cancer. Pathol Int (2002) 0.97
Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int J Nanomedicine (2012) 0.97
Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. Am J Physiol Renal Physiol (2011) 0.97
Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Invest (2008) 0.96
Cribriform-morular variant of papillary thyroid carcinoma: clue to early detection of familial adenomatous polyposis-associated colon cancer. World J Surg (2004) 0.96
Prognostic significance of ki-67 labeling index in papillary thyroid carcinoma. World J Surg (2010) 0.95
Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling. J Biol Chem (2006) 0.95
Cytologic features of hyalinizing trabecular adenoma of the thyroid. Acta Cytol (2003) 0.94
Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease. J Histochem Cytochem (2005) 0.93
Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension (2008) 0.93
Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res (2002) 0.92
Usefulness of ultrasonography for diagnosis of malignant lymphoma of the thyroid. Thyroid (2006) 0.92
Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun (2003) 0.92
Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. ACS Nano (2010) 0.91
Hashimoto's thyroiditis: old concepts and new insights. Curr Opin Rheumatol (2011) 0.91
Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J Invest Dermatol (2002) 0.91
Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A. Biochem Biophys Res Commun (2002) 0.90
Commercially available angiotensin II At₂ receptor antibodies are nonspecific. PLoS One (2013) 0.90
Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis. Cancer Lett (2005) 0.90
Microwave cell death: Enzyme histochemical evaluation for metastatic carcinoma of the liver. Pathol Int (2003) 0.89
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res (2012) 0.89
Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol Int (2003) 0.89
Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol (2005) 0.89